Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Donata David-brown"'
Autor:
Feng Wang, Jordan C. Tsai, Jonathan H. Davis, Bryant Chau, Jia Dong, Sean M. West, Jason M. Hogan, Matthew L. Wheeler, Christine Bee, Winse Morishige, Thomas Cayton, Donata David-brown, Chengyue Zhang, Alexander Kozhich, Tim Sproul, Gavin Dollinger, Arvind Rajpal, Pavel Strop
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
The development of antibody therapeutics relies on animal models that accurately recapitulate disease biology. Syngeneic mouse models are increasingly used with new molecules to capture the biology of complex cancers and disease states, and to provid
Externí odkaz:
https://doaj.org/article/f8bc83b729b6455e90c4ca6aa57051c9
Autor:
Camelia Chiriac, Zheng Ouyang, Linna Wang, Jia Duo, Jon E. Peterson, Donata David-brown, Qin C Ji, Alexander T. Kozhich, Gerard Dalglish
Publikováno v:
SLAS technology. 25(5)
Acoustic liquid handlers deliver small volumes (nL-µL) of multiple fluid types with accuracy and dynamic viscosity profiling. They are widely used in the pharmaceutical industry with applications extending from high-throughput screening in compound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::788be9c919c0f3a15da050806ef086f4
https://pubmed.ncbi.nlm.nih.gov/32351162
https://pubmed.ncbi.nlm.nih.gov/32351162
Autor:
Binodh DeSilva, Alexander T. Kozhich, Rong Liu, Jia Duo, Jon E. Peterson, Jonathan Haulenbeek, Donata David-brown, Lora Hamuro, Linlin Luo, Renuka Pillutla, Steven P. Piccoli, Rasa Santockyte, JoAnne Bruno, Yan J Zhang, Suk Kwok
Publikováno v:
Bioanalysis. 10:559-576
Ligand-binding assay (LBA) performance depends on quality reagents. Strategic reagent screening and characterization is critical to LBA development, optimization and validation. Application of advanced technologies expedites the reagent screening and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7606fddc05b14aaa8d001ee0ec82d4d5
https://doi.org/10.4155/bio-2017-0271
https://doi.org/10.4155/bio-2017-0271
Autor:
Pavel Strop, Feng Wang, Donata David-brown, Bryant Chau, Christine Bee, Jordan C Tsai, Alexander T. Kozhich, Arvind Rajpal, Jason M. Hogan, Sean M. West, Thomas Cayton, Jia Dong, Tim Sproul, Winse Morishige, Matthew L. Wheeler, Jonathan H Davis, Chengyue Zhang, Gavin Dollinger
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The development of antibody therapeutics relies on animal models that accurately recapitulate disease biology. Syngeneic mouse models are increasingly used with new molecules to capture the biology of complex cancers and disease states, and to provid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89c55454f02ef3a8f9046a38a960b5f
https://pubmed.ncbi.nlm.nih.gov/34225582
https://pubmed.ncbi.nlm.nih.gov/34225582